pre-update Archives

Blog

Common Clinical Trial Disclosure Challenges & Potential Solutions

Pharmaceutical companies are being required to be more transparent through the timely disclosure of more…

Certara2023 年 2 月 24 日

网络研讨会点播

FDA Modernization Act 2.0 — 它对药品开发人员意味着什么？

历史上，FDA 要求药物发现与开发项目必须包含动物试验。This…

Danielle Pillsbury2023 年 2 月 21 日

On-Demand Webinar

RAPS Sponsored: How Drug Developers Can Navigate the Inflation Reduction Act

The Inflation Reduction Act (enacted in August 2022) contains profound changes for the healthcare and…

Danielle Pillsbury2023 年 2 月 10 日

On-Demand Webinar

Data Visualization with SEND Data to See What Happened at the Preclinical Phase

SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…

Danielle Pillsbury2023 年 2 月 9 日

White Paper

A Guide to the UK Regulation of Medicines and Medical Devices Post-Brexit

Jim Gallagher2023 年 2 月 8 日

Podcast

Podcast 采访 Dr. Elvira Müller 欧盟联合 HTA - 已决定，但将如何执行，企业应如何准备

In Europe, there are at least as many reimbursement assessment processes in place as European…

Danielle Pillsbury2023 年 2 月 7 日

Announcement

FDA awards new grants to support developing & assessing complex generic drugs

Certara’s Simcyp physiologically-based pharmacokinetic (PBPK) Simulator is being used to verify and expand biosimulation models…

Certara2023 年 2 月 7 日

博客

人工智能：它是什么，以及它如何加速罕见病药物开发？

Large & complex information streams present opportunities for the AI data scientist to aid in…

Certara2023 年 2 月 3 日

On-Demand Webinar

在 Pirana 中使用 Darwin 选择机器学习模型

探索如何通过 Pirana Darwin 模块优化机器学习模型筛选。Watch this on-demand…

Danielle Pillsbury2023 年 2 月 3 日

White Paper

Certara’s combined PBPK/QSP model predicts safety and efficacy biomarker outcomes in Alzheimer’s Disease, as demonstrated in recent lecanemab work with Eisai

Jim Gallagher2023 年 2 月 2 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

pre-update

Common Clinical Trial Disclosure Challenges & Potential Solutions

FDA Modernization Act 2.0 — 它对药品开发人员意味着什么？

RAPS Sponsored: How Drug Developers Can Navigate the Inflation Reduction Act

Data Visualization with SEND Data to See What Happened at the Preclinical Phase

A Guide to the UK Regulation of Medicines and Medical Devices Post-Brexit

Podcast 采访 Dr. Elvira Müller 欧盟联合 HTA - 已决定，但将如何执行，企业应如何准备

FDA awards new grants to support developing & assessing complex generic drugs

人工智能：它是什么，以及它如何加速罕见病药物开发？

在 Pirana 中使用 Darwin 选择机器学习模型

Certara’s combined PBPK/QSP model predicts safety and efficacy biomarker outcomes in Alzheimer’s Disease, as demonstrated in recent lecanemab work with Eisai

订阅时事通讯

快捷链接

解决方案

联系我们